Cypress Capital Group Reduces Stock Position in Mettler-Toledo International Inc. (NYSE:MTD)

Cypress Capital Group lessened its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 6.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 477 shares of the medical instruments supplier’s stock after selling 35 shares during the quarter. Cypress Capital Group’s holdings in Mettler-Toledo International were worth $667,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of MTD. Atlantic Union Bankshares Corp boosted its stake in Mettler-Toledo International by 22.7% in the second quarter. Atlantic Union Bankshares Corp now owns 1,829 shares of the medical instruments supplier’s stock valued at $2,556,000 after acquiring an additional 338 shares in the last quarter. Family Firm Inc. acquired a new stake in shares of Mettler-Toledo International during the second quarter worth about $25,000. Slow Capital Inc. boosted its stake in shares of Mettler-Toledo International by 1.3% during the second quarter. Slow Capital Inc. now owns 2,228 shares of the medical instruments supplier’s stock worth $3,113,000 after buying an additional 28 shares during the period. Eads & Heald Wealth Management boosted its stake in shares of Mettler-Toledo International by 13.8% during the second quarter. Eads & Heald Wealth Management now owns 364 shares of the medical instruments supplier’s stock worth $509,000 after buying an additional 44 shares during the period. Finally, Lecap Asset Management Ltd. acquired a new stake in shares of Mettler-Toledo International during the second quarter worth about $583,000. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 250 shares of Mettler-Toledo International stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total value of $350,250.00. Following the transaction, the chief financial officer now owns 4,914 shares in the company, valued at approximately $6,884,514. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, CFO Shawn Vadala sold 250 shares of Mettler-Toledo International stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the transaction, the chief financial officer now owns 4,914 shares in the company, valued at approximately $6,884,514. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Christian Magloth sold 1,000 shares of Mettler-Toledo International stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the transaction, the insider now owns 734 shares in the company, valued at approximately $1,044,459.98. The disclosure for this sale can be found here. 1.94% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on MTD. StockNews.com upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a research note on Thursday, July 11th. The Goldman Sachs Group increased their target price on shares of Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the company a “neutral” rating in a report on Tuesday, July 9th. JPMorgan Chase & Co. increased their target price on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a report on Monday, August 5th. Citigroup increased their target price on shares of Mettler-Toledo International from $975.00 to $1,200.00 and gave the company a “sell” rating in a report on Monday, May 13th. Finally, Evercore ISI increased their target price on shares of Mettler-Toledo International from $1,375.00 to $1,390.00 and gave the company an “in-line” rating in a report on Tuesday, July 2nd. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, Mettler-Toledo International has an average rating of “Hold” and a consensus price target of $1,343.75.

Mettler-Toledo International Stock Performance

NYSE MTD traded up $0.77 during mid-day trading on Monday, reaching $1,436.71. 3,746 shares of the stock were exchanged, compared to its average volume of 140,447. Mettler-Toledo International Inc. has a 1-year low of $928.49 and a 1-year high of $1,546.93. The business’s fifty day simple moving average is $1,405.01 and its 200 day simple moving average is $1,349.85. The stock has a market capitalization of $30.68 billion, a PE ratio of 40.27, a PEG ratio of 4.06 and a beta of 1.17.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 earnings per share for the quarter, beating analysts’ consensus estimates of $9.00 by $0.65. The company had revenue of $946.75 million for the quarter, compared to analyst estimates of $929.13 million. Mettler-Toledo International had a net margin of 20.95% and a negative return on equity of 590.80%. Mettler-Toledo International’s revenue for the quarter was down 3.6% on a year-over-year basis. During the same quarter last year, the business earned $10.19 EPS. On average, analysts anticipate that Mettler-Toledo International Inc. will post 40.13 EPS for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.